Summary & Overview
HCPCS E1905: Virtual Reality Cognitive Behavioral Therapy Device
HCPCS Level II code E1905 identifies a virtual reality cognitive behavioral therapy device and its pre-programmed therapy software. As virtual and device-delivered behavioral health interventions expand, this code captures a specific technology-enabled therapeutic modality that can affect coverage, billing workflows, and device procurement decisions nationally. The code matters as payers and clinicians integrate digital therapeutics into behavioral health care and seek consistent billing pathways for device-based CBT.
Key payers included in the analysis are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of reimbursement benchmarks, payer coverage considerations, and the clinical context for device-delivered CBT. The publication outlines how E1905 is used to represent the device and software package, typical sites of service where the device is deployed, and common billing modifiers associated with device and procedural services when available. Where input data is missing, the text notes that information is not available in the input.
This summary provides clinicians, billing professionals, and policy analysts with a national perspective on the role of HCPCS Level II code E1905 in documenting virtual reality CBT devices, helping stakeholders locate relevant benchmark and policy topics related to digital behavioral therapeutics.
Billing Code Overview
HCPCS Level II code E1905 describes a virtual reality cognitive behavioral therapy device (CBT), including pre-programmed therapy software. This code represents a technology-based therapeutic device intended to deliver cognitive behavioral therapy via virtual reality platforms.
-
Service type: Device-based cognitive behavioral therapy delivered through a virtual reality platform and bundled software
-
Typical site of service: Outpatient clinics, behavioral health centers, telehealth-capable settings, and other ambulatory care environments where device-based therapeutic interventions are provided
Clinical & Coding Specifications
Clinical Context
A 34-year-old outpatient with generalized anxiety disorder and comorbid insomnia is referred to a behavioral health clinic for augmentation of psychotherapy. The clinic provides a prescription for a virtual reality cognitive behavioral therapy device billed under E1905 that includes pre-programmed CBT modules addressing exposure, relaxation training, and cognitive restructuring. The patient completes an initial in-person intake with a licensed psychologist who documents baseline symptom scores (GAD-7, PHQ-9, Insomnia Severity Index), assesses suitability for VR therapy (seizure history, vestibular disorders, severe motion sickness), and obtains informed consent for device use.
The typical workflow: the device is dispensed or set up in clinic and configured for the patient’s treatment plan. The patient completes supervised VR sessions on-site for the first one to three exposures to monitor for adverse effects and to instruct on safe use. Subsequent sessions may occur in clinic, at home with remote monitoring, or as part of a hybrid model. Clinicians document session duration, therapy module used, patient response, and any device-related issues. Follow-up visits reassess symptoms and determine ongoing need for device-based CBT. Billing for the device is submitted using E1905 with applicable modifiers to indicate unusual circumstances (for example, significant additional work or patient transfer of care). Payors involved may include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, BUCA, and Medicare depending on patient coverage.
Coding Specifications
| Modifier | Description | When to Use |
|---|